Hogan Lovells Publications
Podcast: Talking the cure
26 August 2020
Charlotte Damiano
PartnerParis
Charlotte Damiano is a partner in our Global Regulatory practice, with extensive experience in health law.
She represents major pharmaceutical companies in litigation relating to tax and social security matters. She also advises companies on pricing, reimbursement for medications and medical devices, and more generally on market access issues, including in disputes with the French health authorities.
Prior to joining Hogan Lovells, Charlotte practiced in a London-based international law firm.
Awards and recognitions
2020
Recommended in Healthcare
Who's Who Legal
Education and admissions
Education
DEA in Economics and Business Law, Université Nice Sophia Antipolis School of Law
Bar admissions and qualifications
Paris
Latest thinking and events
Insights
The French "safeguard clause for medical devices” – a critical assessment
Registered Content
30 March 2020
News
The French "safeguard clause for medical devices” – a critical assessment
Registered Content
30 March 2020
Hogan Lovells Publications
Clawbacks negotiated on the price of pharmaceutical products and pharmaceutical companies’ turnover defined
18 March 2020
The "safeguard clause for medical devices" (clause de sauvegarde dispositifs médicaux), an opportunity to make a critical assessment in the light of the "safeguard clause for pharmaceutical products" (clause de sauvegarde médicaments).
06 February 2020
Hogan Lovells Publications
View from the Horizon: Pricing and financial regulation of health products in France
25 July 2019
